HPV Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4103215
- 93 Pages
- November 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global HPV Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global HPV Testing market segmented into
Cervical Cancer Screening
Follow-up HPV Testing
Co-testing
Based on the end-use, the global HPV Testing market classified into
Cervical Cancer Screening
Vaginal Cancer Screening
Based on geography, the global HPV Testing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Roche Diagnostics
Qiagen
Hologic
Abbott Laboratories
BD
Seegene.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HPV TESTING INDUSTRY
2.1 Summary about HPV Testing Industry
2.2 HPV Testing Market Trends
2.2.1 HPV Testing Production & Consumption Trends
2.2.2 HPV Testing Demand Structure Trends
2.3 HPV Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 HPV Testing
4.2.2 Follow-up HPV Testing
4.2.3 Co-testing
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Cervical Cancer Screening
4.3.2 Vaginal Cancer Screening
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 HPV Testing
5.2.2 Follow-up HPV Testing
5.2.3 Co-testing
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Cervical Cancer Screening
5.3.2 Vaginal Cancer Screening
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 HPV Testing
6.2.2 Follow-up HPV Testing
6.2.3 Co-testing
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Cervical Cancer Screening
6.3.2 Vaginal Cancer Screening
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 HPV Testing
7.2.2 Follow-up HPV Testing
7.2.3 Co-testing
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Cervical Cancer Screening
7.3.2 Vaginal Cancer Screening
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 HPV Testing
8.2.2 Follow-up HPV Testing
8.2.3 Co-testing
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Cervical Cancer Screening
8.3.2 Vaginal Cancer Screening
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 HPV Testing
9.2.2 Follow-up HPV Testing
9.2.3 Co-testing
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Cervical Cancer Screening
9.3.2 Vaginal Cancer Screening
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche Diagnostics
10.1.2 Qiagen
10.1.3 Hologic
10.1.4 Abbott Laboratories
10.1.5 BD
10.1.6 Seegene.
10.2 HPV Testing Sales Date of Major Players (2017-2020e)
10.2.1 Roche Diagnostics
10.2.2 Qiagen
10.2.3 Hologic
10.2.4 Abbott Laboratories
10.2.5 BD
10.2.6 Seegene.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table HPV Testing Product Type Overview
2.Table HPV Testing Product Type Market Share List
3.Table HPV Testing Product Type of Major Players
4.Table Brief Introduction of Roche Diagnostics
5.Table Brief Introduction of Qiagen
6.Table Brief Introduction of Hologic
7.Table Brief Introduction of Abbott Laboratories
8.Table Brief Introduction of BD
9.Table Brief Introduction of Seegene.
10.Table Products & Services of Roche Diagnostics
11.Table Products & Services of Qiagen
12.Table Products & Services of Hologic
13.Table Products & Services of Abbott Laboratories
14.Table Products & Services of BD
15.Table Products & Services of Seegene.
16.Table Market Distribution of Major Players
17.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
18.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
19.Table Global HPV Testing Market Forecast (Million USD) by Region 2021f-2026f
20.Table Global HPV Testing Market Forecast (Million USD) Share by Region 2021f-2026f
21.Table Global HPV Testing Market Forecast (Million USD) by Demand 2021f-2026f
22.Table Global HPV Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
